Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Revenue and Segment Performance
TMO logo

Thermo Fisher Revenues Hit $11 Billion as $8.9 Billion Clario Acquisition Drives Growth

TMO10-QFiling Date: 5/1/2026
Thermo Fisher Scientific Inc.
Description

What this story covers

Thermo Fisher Scientific reported $11.0 billion in Q1 2026 revenue, a 6% increase driven by the Clario acquisition. Despite muted academic demand and China headwinds, adjusted EPS rose 6% to $5.44, supported by robust bioproduction and clinical research.

Story snapshot

CompanyThermo Fisher Scientific Inc.
TickerTMO
VariantStandard detailed
Duration13:03
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000097745-26-000092
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in